Manufacturer 340B Restriction Access Impact Syndicated Report

Slide 1
mmit-logo-white

Infographic

Manufacturer 340B Restriction Access Impact Syndicated Report

infographic-manufacturers-340b-thumbnail
pricing-strategy-icon
340B drug pricing program overview and trends.
icon-website
Contract pharmacy restriction policy dynamics.
reimbursement-icon
Mistaken 340B pricing blocks, stakeholders and access impact.
Slide

Manufacturers increasingly have been implementing restrictions on covered entities’ contract pharmacy use to prevent diversion and duplicate discounts, safeguard program integrity and promote transparency. Given variability in manufacturer policies and impact on covered entity revenue, it is critical for manufacturers to understand account response strategy and willingness to implement access restrictions on impacted and portfolio products.

Access the Infographic